New user? / Forgot your password?
0 Item | 0,00 €
Heptenophos
| Item number | 676023 |
| CAS | 23560-59-0 |
| Formula | C9H12ClO4P |
| Molecular weight | 250,61 g/mol |
| Quantity | 1X100MG |
| storage conditions | 4 °C |
| CoA / MSDS | Retrieve CoA Retrieve MSDS |
Price | Please log in. |
Part of Product groups:
Product Variations:
Product | Catalog No./ CAS No. | Quantity | Price | |
|---|---|---|---|---|
 | 676023 | 1X100MG | Please log in. | |
Heptenophos solution |  | 676902 | 1X10ML | Please log in. |
Heptenophos solution |  | 678429 | 1X1ML | Please log in. |
Heptenophos solution |  | 691551 | 1X1ML | Please log in. |
| Safety Data Sheet | according to Regulation (EC) No 1907/2006 (REACH) Classifications according to Regulation (EC) No 1272/2008. Printdate 08.09.2024 |
| IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING | |
| Product name: | Heptenophos |
| Catalog No.: | 676023 |
| Relevant identified uses of the substance or mixture | Identified: Laboratory chemical uses: R&D |
| Uses advised against: | HPC Standards GmbH Am Wieseneck 7 04451 Cunnersdorf Deutschland Tel. +49 34291 3372-36 Fax. +49 34291 3372-39 contact@hpc-standards.com |
| Emergency telephone number | HPC Standards Tel. +49 34291 3372-36 This number is only available during office hours. |
| HAZARDS IDENTIFICATION | 2.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 3), H301 Acute toxicity, Inhalation (Category 2), H330 Acute toxicity, Dermal (Category 4), H312 Short-term (acute) aquatic hazard (Category 1), H400 Long-term (chronic) aquatic hazard (Category 1), H410 For the full text of the H-Statements mentioned in this Section, see Section 16. |
| Label elements | |
| Pictogram | GHS06 skull skull GHS09 Aquatic-pollut-red Aquatic-pollut-red |
| 2.2 Label elements Labelling according Regulation (EC) No 1272/2008 Pictogram Signal Word Danger Hazard statement(s) H301 Toxic if swallowed. H312 Harmful in contact with skin. H330 Fatal if inhaled. H410 Very toxic to aquatic life with long lasting effects. Precautionary statement(s) P260 Do not breathe mist or vapors. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. Supplemental Hazard Statements none Reduced Labeling (<= 125 ml) Pictogram Signal Word Danger Hazard statement(s) H301 Toxic if swallowed. H330 Fatal if inhaled. Precautionary statement(s) P260 Do not breathe mist or vapors. P264 Wash skin thoroughly after handling. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. Supplemental Hazard Statements none 2.3 Other hazards This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. | |
| COMPOSITION/INFORMATION ON INGREDIENTS | 3.1 Substances Formula : C9H12ClO4P Molecular weight : 250,62 g/mol CAS-No. : 23560-59-0 EC-No. : 245-737-0 Index-No. : 015-126-00-1 Component Heptenophos CAS-No. : 23560-59-0 EC-No. : 245-737-0 Index-No. : 015-126-00-1 Classification Acute Tox. 3; Acute Tox. 2; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1; H301, H330, H312, H400, H410 M-Factor - Aquatic Acute: 10 - Aquatic Chronic: 10 Concentration <= 100 % For the full text of the H-Statements mentioned in this Section, see Section 16. |
| Formula | C9H12ClO4P |
| Molecular Weight (g/mol) | 250.61 |
| CAS-No. | 23560-59-0 |
| FIRST AID MEASURES | 4.1 Description of first-aid measures General advice First aiders need to protect themselves. Show this material safety data sheet to the doctor in attendance. If inhaled After inhalation: fresh air. Immediately call in physician. If breathing stops: immediately apply artificial respiration, if necessary also oxygen. In case of skin contact In case of skin contact: Take off immediately all contaminated clothing. Rinse skin with water/ shower. Consult a physician. In case of eye contact After eye contact: rinse out with plenty of water. Remove contact lenses. If swallowed If swallowed: give water to drink (two glasses at most). Seek medical advice immediately. In exceptional cases only, if medical care is not available within one hour, induce vomiting (only in persons who are wide awake and fully conscious), administer activated charcoal (20 - 40 g in a 10% slurry) and consult a doctor as quickly as possible. 4.2 Most important symptoms and effects, both acute and delayed The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 4.3 Indication of any immediate medical attention and special treatment needed No data available |
| FIRE-FIGHTING MEASURES | 5.1 Extinguishing media Suitable extinguishing media Water Foam Carbon dioxide (CO2) Dry powder Unsuitable extinguishing media For this substance/mixture no limitations of extinguishing agents are given. 5.2 Special hazards arising from the substance or mixture Carbon oxides Oxides of phosphorus Hydrogen chloride gas Combustible. Development of hazardous combustion gases or vapours possible in the event of fire. 5.3 Advice for firefighters Stay in danger area only with self-contained breathing apparatus. Prevent skin contact by keeping a safe distance or by wearing suitable protective clothing. 5.4 Further information Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent fire extinguishing water from contaminating surface water or the ground water system. |
| ACCIDENTAL RELEASE MEASURES | 6.1 Personal precautions, protective equipment and emergency procedures Advice for non-emergency personnel: Do not breathe vapors, aerosols. Avoid substance contact. Ensure adequate ventilation. Evacuate the danger area, observe emergency procedures, consult an expert. For personal protection see section 8. 6.2 Environmental precautions Do not let product enter drains. 6.3 Methods and materials for containment and cleaning up Cover drains. Collect, bind, and pump off spills. Observe possible material restrictions (see sections 7 and 10). Take up carefully with liquid-absorbent material (e.g. Chemizorb®). Dispose of properly. Clean up affected area. 6.4 Reference to other sections For disposal see section 13. |
| HANDLING AND STORAGE | 7.1 Precautions for safe handling Advice on safe handling Work under hood. Do not inhale substance/mixture. Avoid generation of vapours/aerosols. Hygiene measures Immediately change contaminated clothing. Apply preventive skin protection. Wash hands and face after working with substance. For precautions see section 2.2. 7.2 Conditions for safe storage, including any incompatibilities Storage conditions Tightly closed. Keep in a well-ventilated place. Keep locked up or in an area accessible only to qualified or authorized persons. Storage stability Recommended storage temperature -25 - -10 °C Storage class Storage class (TRGS 510): 6.1B: Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials 7.3 Specific end use(s) Apart from the uses mentioned in section 1.2 no other specific uses are stipulated |
| EXPOSURE CONTROLS/PERSONAL PROTECTION | 8.1 Control parameters Ingredients with workplace control parameters 8.2 Exposure controls Personal protective equipment Eye/face protection Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Safety glasses Skin protection required Body Protection protective clothing Respiratory protection required when vapours/aerosols are generated. Our recommendations on filtering respiratory protection are based on the following standards: DIN EN 143, DIN 14387 and other accompanying standards relating to the used respiratory protection system. Recommended Filter type: Filter type ABEK The entrepeneur has to ensure that maintenance, cleaning and testing of respiratory protective devices are carried out according to the instructions of the producer. These measures have to be properly documented. Control of environmental exposure Do not let product enter drains. |
| PHYSICAL AND CHEMICAL PROPERTIES | 9.1 Information on basic physical and chemical properties a) Physical state liquid b) Color brown c) Odor No data available d) Melting point/freezing point No data available e) Initial boiling point and boiling range 64 °C at 0,104 hPa f) Flammability (solid, gas) No data available g) Upper/lower flammability or explosive limits No data available h) Flash point No data available i) Autoignition temperature No data available j) Decomposition temperature No data available k) pH No data available l) Viscosity Viscosity, kinematic: No data available Viscosity, dynamic: No data available m) Water solubility insoluble n) Partition coefficient: n-octanol/water No data available o) Vapor pressure 0,002 hPa at 25 °C 0,001 hPa at 15 °C p) Density 1,28 g/cm3 at 20 °C Relative density No data available q) Relative vapor density No data available r) Particle characteristics No data available s) Explosive properties No data available t) Oxidizing properties No data available 9.2 Other safety information No data available |
| STABILITY AND REACTIVITY | 10.1 Reactivity No data available 10.2 Chemical stability The product is chemically stable under standard ambient conditions (room temperature) . 10.3 Possibility of hazardous reactions No data available 10.4 Conditions to avoid no information available 10.5 Incompatible materials Strong oxidizing agents 10.6 Hazardous decomposition products In the event of fire: see section 5 |
| TOXICOLOGICAL INFORMATION | 11.1 Information on toxicological effects Acute toxicity LD50 Oral - Rat - 96 mg/kg LC50 Inhalation - Rat - 4 h - 400 mg/m3 - dust/mist LD50 Dermal - Rat - 2.000 mg/kg Remarks: Sense Organs and Special Senses (Nose, Eye, Ear, and Taste):Eye:Other. Behavioral:Muscle contraction or spasticity. Diarrhea Skin corrosion/irritation Remarks: No data available Serious eye damage/eye irritation Remarks: No data available Respiratory or skin sensitization No data available Germ cell mutagenicity No data available Carcinogenicity No data available Reproductive toxicity No data available Specific target organ toxicity - single exposure No data available Specific target organ toxicity - repeated exposure No data available Aspiration hazard No data available 11.2 Additional Information Endocrine disrupting properties Product: Assessment : The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. RTECS: TB8545000 Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting, Dizziness, Drowsiness, Confusion., Weakness, Muscle cramps/spasms., Change in pupil size., Fever, Seizures., Incoordination. |
| ECOLOGICAL INFORMATION | 12.1 Toxicity No data available 12.2 Persistence and degradability No data available 12.3 Bioaccumulative potential No data available 12.4 Mobility in soil No data available 12.5 Results of PBT and vPvB assessment This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 12.6 Endocrine disrupting properties Product: Assessment : The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. 12.7 Other adverse effects No data available |
| DISPOSAL CONSIDERATIONS | 13.1 Waste treatment methods No data available |
| TRANSPORT INFORMATION | 14.1 UN number ADR/RID: 2810 IMDG: 2810 IATA: 2810 14.2 UN proper shipping name ADR/RID: TOXIC LIQUID, ORGANIC, N.O.S. (Heptenophos) IMDG: TOXIC LIQUID, ORGANIC, N.O.S. (Heptenophos) IATA: Toxic liquid, organic, n.o.s. (Heptenophos) 14.3 Transport hazard class(es) ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1 14.4 Packaging group ADR/RID: III IMDG: III IATA: III 14.5 Environmental hazards ADR/RID: no IMDG Marine pollutant: yes IATA: no 14.6 Special precautions for user No data available |
| REGULATORY INFORMATION | 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture This material safety data sheet complies with the requirements of Regulation (EC) No. 1907/2006. National legislation Seveso III: Directive 2012/18/EU of the European Parliament and of the Council on the control of major-accident hazards involving dangerous substances. : ACUTE TOXIC : ENVIRONMENTAL HAZARDS Other regulations Observe work restrictions regarding maternity protection in accordance to Dir 92/85/EEC or stricter national regulations where applicable. Take note of Dir 94/33/EC on the protection of young people at work. 15.2 Chemical Safety Assessment For this product a chemical safety assessment was not carried out |
| OTHER INFORMATION | The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. For lab use only! |